Lung deposition of inhaled drugs increases with age

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 5, 2000, Pages 1819-1822

  Anhoj, J ^a   Thorsson, L ^a   Bisgaard, H ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; HUMAN; LUNG DEPOSIT; METERED DOSE INHALER; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0033678998     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.5.2002132     Document Type: Article

References (22)

1. A study of the mechanism of the antiasthmatic action of inhaled budesonide
2. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity
3. A non-electrostatic spacer for aerosol delivery
4. A metal aerosol holding chamber devised for young children with asthma
5. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid
6. Lung deposition of budesonide from a pressurized metered-dose inhaler attached to a spacer
7. The influence of orally deposited budesonide on systemic availability of budesonide after inhalation from a Turbohaler
8. Budesonide CIR capsules in children and adults with Crohn's disease: A pharmacokinetic and tolerability study
9. In vitro properties of pressurized metered dose inhalers with and without spacer devices
10. Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children
11. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction
12. Lung deposition of budesonide from Turbohaler in asthmatic children
13. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma
14. The influence on aerosol deposition in children with cystic fibrosis
15. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children
16. Lung deposition and systemic availability of budesonide inhaled as nebulised suspension from different nebulisers
17. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients
18. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children
19. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man
20. Particle deposition and resistance in the noses of adults and children